SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-016278
Filing Date
2010-03-29
Accepted
2010-03-29 16:08:28
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v178404_10k.htm 10-K 1507491
2 v178404_ex10-9.htm EX-10.9 779
3 GRAPHIC v178404_ex10-9x1x1.jpg GRAPHIC 69828
4 GRAPHIC v178404_ex10-9x2x1.jpg GRAPHIC 110337
5 GRAPHIC v178404_ex10-9x3x1.jpg GRAPHIC 105210
6 GRAPHIC v178404_ex10-9x4x1.jpg GRAPHIC 30651
7 v178404_ex31.htm EX-31 18177
8 v178404_ex32.htm EX-32 7295
  Complete submission text file 0001144204-10-016278.txt   1971282
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 10710814
SIC: 2834 Pharmaceutical Preparations